| Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium IG McKeith, BF Boeve, DW Dickson, G Halliday, JP Taylor, D Weintraub, ... Neurology 89 (1), 88-100, 2017 | 3953 | 2017 |
| Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines I Litvan, JG Goldman, AI Tröster, BA Schmand, D Weintraub, RC Petersen, ... Movement disorders 27 (3), 349-356, 2012 | 2880 | 2012 |
| Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria GU Höglinger, G Respondek, M Stamelou, C Kurz, KA Josephs, AE Lang, ... Movement disorders 32 (6), 853-864, 2017 | 2019 | 2017 |
| Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity L Cantuti-Castelvetri, R Ojha, LD Pedro, M Djannatian, J Franz, ... Science 370 (6518), 856-860, 2020 | 1894 | 2020 |
| The Parkinson progression marker initiative (PPMI) K Marek, D Jennings, S Lasch, A Siderowf, C Tanner, T Simuni, C Coffey, ... Progress in neurobiology 95 (4), 629-635, 2011 | 1721 | 2011 |
| A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease A Zimprich, A Benet-Pagès, W Struhal, E Graf, SH Eck, MN Offman, ... The American Journal of Human Genetics 89 (1), 168-175, 2011 | 1106 | 2011 |
| MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD‐MCI I Litvan, D Aarsland, CH Adler, JG Goldman, J Kulisevsky, B Mollenhauer, ... Movement disorders 26 (10), 1814-1824, 2011 | 1011 | 2011 |
| Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study RB Postuma, A Iranzo, M Hu, B Högl, BF Boeve, R Manni, WH Oertel, ... Brain 142 (3), 744-759, 2019 | 901 | 2019 |
| α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study B Mollenhauer, JJ Locascio, W Schulz-Schaeffer, F Sixel-Döring, ... The Lancet Neurology 10 (3), 230-240, 2011 | 723 | 2011 |
| CSF and blood biomarkers for Parkinson's disease L Parnetti, L Gaetani, P Eusebi, S Paciotti, O Hansson, O El-Agnaf, ... The Lancet Neurology 18 (6), 573-586, 2019 | 595 | 2019 |
| The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder A Heintz‐Buschart, U Pandey, T Wicke, F Sixel‐Döring, A Janzen, ... Movement disorders 33 (1), 88-98, 2018 | 585 | 2018 |
| A practical guide to immunoassay method validation U Andreasson, A Perret-Liaudet, LJC van Waalwijk van Doorn, ... Frontiers in neurology 6, 179, 2015 | 544 | 2015 |
| Characterizing mild cognitive impairment in incident Parkinson disease: the ICICLE-PD study AJ Yarnall, DP Breen, GW Duncan, TK Khoo, SY Coleman, MJ Firbank, ... Neurology 82 (4), 308-316, 2014 | 503 | 2014 |
| The Parkinson's progression markers initiative (PPMI)–establishing a PD biomarker cohort K Marek, S Chowdhury, A Siderowf, S Lasch, CS Coffey, ... Annals of clinical and translational neurology 5 (12), 1460-1477, 2018 | 484 | 2018 |
| Induction of α-synuclein aggregate formation by CSF exosomes from patients with Parkinson’s disease and dementia with Lewy bodies A Stuendl, M Kunadt, N Kruse, C Bartels, W Moebius, KM Danzer, ... Brain 139 (2), 481-494, 2016 | 465 | 2016 |
| Direct quantification of CSF α-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration B Mollenhauer, V Cullen, I Kahn, B Krastins, TF Outeiro, I Pepivani, J Ng, ... Experimental neurology 213 (2), 315-325, 2008 | 460 | 2008 |
| Development of a biochemical diagnosis of Parkinson disease by detection of α-synuclein misfolded aggregates in cerebrospinal fluid M Shahnawaz, T Tokuda, M Waragai, N Mendez, R Ishii, C Trenkwalder, ... JAMA neurology 74 (2), 163-172, 2017 | 458 | 2017 |
| Association of Cerebrospinal Fluid β-Amyloid 1-42, T-tau, P-tau181, and α-Synuclein Levels With Clinical Features of Drug-Naive Patients With Early Parkinson … JH Kang, DJ Irwin, AS Chen-Plotkin, A Siderowf, C Caspell, CS Coffey, ... JAMA neurology 70 (10), 2013 | 455 | 2013 |
| Associated factors for REM sleep behavior disorder in Parkinson disease F Sixel-Döring, E Trautmann, B Mollenhauer, C Trenkwalder Neurology 77 (11), 1048-1054, 2011 | 378 | 2011 |
| Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study A Siderowf, L Concha-Marambio, DE Lafontant, CM Farris, Y Ma, ... The Lancet Neurology 22 (5), 407-417, 2023 | 373 | 2023 |
